Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Published Date: 25 Dec 2024

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers explore e-bikes for cancer recovery

2.

BMI is linked to heart damage from chemotherapy in breast cancer patients.

3.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

4.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

5.

In inflammatory breast cancer, ER beta regulates estrogen signaling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot